App is temporarily unavailable
Description
恒康药业在线APP致力于通过移动互联网服务医药公司、医院、卫生院、诊所、药店等企业，提供便捷的掌上采购系统，客户提供实时询价、便捷的一键下单采购服务以及售后服务。
Screenshots
恒康医药 FAQ
-
Is 恒康医药 free?
Yes, 恒康医药 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 恒康医药 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 恒康医药 cost?
恒康医药 is free.
-
What is 恒康医药 revenue?
To get estimated revenue of 恒康医药 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Sweden yet.
Ratings History
恒康医药 Reviews
恒康医药 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
华洲医药
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
生命元医药
生命元医药 - B2B药品采购平台
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
福济药业
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
国丰药业
|
Unlock
|
Unlock
|
0
|
|
4 years ago | |
民信医药
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
天宇药业
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
乐生堂
N/A
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
弘林医药
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
药药购
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
N/A
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
恒康医药 Installs
Last 30 days
恒康医药 Revenue
Last 30 days恒康医药 Revenue and Downloads
Gain valuable insights into 恒康医药 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Unknown
- Languages
- English
- Recent release
- 1.3 (2 years ago )
- Released on
- Feb 27, 2021 (3 years ago )
- Also available in
- China, Russia, Kazakhstan, Lebanon, Malaysia, Nigeria, Norway, New Zealand, Peru, Philippines, Pakistan, Poland, Portugal, Japan, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, United States, Vietnam, South Africa, Egypt, Austria, Australia, Belarus, Canada, Switzerland, Chile, Czechia, Germany, Denmark, Algeria, United Arab Emirates, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Ireland, India, Italy
- Last Updated
- 1 year ago